Home › Funds › Ally Bridge Group (NY) LLC › CATX
Ally Bridge Group (NY) LLC position in CATX
PERSPECTIVE THERAPEUTICS INC · Health Care
Ally Bridge Group (NY) LLC reported holding 743,958 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 2.24% of its reported portfolio and ranking #18 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed CATX holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's CATX position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in CATX in Q2 2024 at 396,242 shares (US$4.0M). The position peaked in Q3 2024 at 341,739 shares, worth US$4.6M. Across 4 filings, Ally Bridge Group (NY) LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 743,958 shares valued at US$2.5M — a reduction of -182,599 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 396.24K | $3.95M | New |
| Q3 2024 | 341.74K | $4.56M | Reduce |
| Q1 2026 | 926.56K | $3.86M | New |
| Q2 2026 | 743.96K | $2.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATX and 13F data
CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Avidity Partners Management LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATX
- TCG Crossover Management, LLC 7.92M sh · $26.99M · Q2 2026
- Commodore Capital LP 6.34M sh · $21.61M · Q2 2026
- Avidity Partners Management LP 6.30M sh · $21.48M · Q2 2026
- Affinity Asset Advisors, LLC 4.21M sh · $14.37M · Q2 2026
- Spruce Street Capital LP 3.69M sh · $12.60M · Q2 2026
- Nicholson Wealth Management Group, LLC 1.62M sh · $5.52M · Q2 2026
- Yu Fan 1.06M sh · $3.60M · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held CATX?
Ally Bridge Group (NY) LLC has disclosed CATX holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
What is Ally Bridge Group (NY) LLC's current position in CATX?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 743.96K shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $2.54M, representing 2.24% of its reported portfolio and ranking #18.
Has Ally Bridge Group (NY) LLC been buying or selling CATX?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in CATX. The position peaked in Q3 2024 at 341.74K shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Avidity Partners Management LP, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.